Counterfeit drugs and medical devices are a pervasive problem for the pharmaceutical industry and for consumers. It’s an issue that affects countries around the world, according to SICPA, a firm that has developed secured identification and traceability solutions for companies to assess and manage risks to their products.
“In places like Sub-Saharan Africa, 30-40% of all medicines are believed and documented to be counterfeit,” SICPA’s VP Richard Einhorn told Drug Delivery Business News.
Get the full story at our sister site, Drug Delivery Business News.
The post SICPA aims to arm companies against counterfeit drugs, devices appeared first on MassDevice.